Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

How does skin irritation respond to lurbinectedin dose changes?

See the DrugPatentWatch profile for lurbinectedin

How does skin irritation respond to lurbinectedin dose changes?

Lurbinectedin is a selective inhibitor of oncogenic transcription used to treat relapsed small cell lung cancer. The drug comes in a single-use vial with 4 mg of powder reconstituted with 8 mL of sterile water, reconstituted solution stability lasts 24 hours at 4° C or 8 hours at room temperature.

Skin irritation, itching, and rash are reported adverse events in patients receiving lurbinectedin. These events occur at rates of 8–22% depending on the study.



Other Questions About Lurbinectedin :

prevalence in the european union in 2019, lurbinectedin lurbinectedin 가격 How often should lurbinectedin be re evaluated during disease progression? What's the impact of lurbinectedin on managing immunotherapy toxicity? Would you consider lurbinectedin retreatment? Are there specific late side effects that require more frequent monitoring in lurbinectedin treated patients? Can lurbinectedin cross the placenta?